Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome

Andelyn Biosciences United Kingdom United States of America

View original content:https://www.prnewswire.co.uk/news-releases/andelyn-biosciences-selected-by-ultragenyx-for-late-stage-process-performance-qualification-ppq-manufacturing-of-novel-gene-therapy-for-sanfilippo-syndrome-302017893.html